GYRE insider buying & filings

GYREGYRE THERAPEUTICS, INC.

NasdaqCM · Healthcare · $683.65M

$6.44

+1.26% · Sep 3

30 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jun 22 · scanned 8m ago

Price · 1Y · daily● 13 sells

▸ hover a marker for the filing · drag to zoom

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$683.65M

Float

35.9M

34% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

107.5

Price / sales

6.2

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jun 22SELLYe WeiguoChief Operating Officerdirect3,000 @ $6.35$19.1K

Jun 22EXERCISEYe WeiguoChief Operating Officerdirect3,000 @ $0.7500$2.3K

Jun 22SELLYe WeiguoChief Operating Officerdirect5,000 @ $6.24$31.2K

Jun 22EXERCISEYe WeiguoChief Operating Officerdirect5,000 @ $0.7500$3.8K

Jun 22SELLYe WeiguoChief Operating Officerdirect3,000 @ $6.15$18.4K

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice